PT Pyridam Farma Tbk (ISX:PYFA) 3-Year EBITDA Growth Rate : -22.50% (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is PT Pyridam Farma Tbk 3-Year EBITDA Growth Rate?

PT Pyridam Farma Tbk's EBITDA per Share for the three months ended in Sep. 2024 was Rp-2.33.

During the past 12 months, PT Pyridam Farma Tbk's average EBITDA Per Share Growth Rate was -186.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -22.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 32.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 20.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of PT Pyridam Farma Tbk was 181.80% per year. The lowest was -22.50% per year. And the median was 17.20% per year.

Competitive Comparison of PT Pyridam Farma Tbk's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, PT Pyridam Farma Tbk's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Pyridam Farma Tbk's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Pyridam Farma Tbk's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where PT Pyridam Farma Tbk's 3-Year EBITDA Growth Rate falls into.

PT Pyridam Farma Tbk 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

PT Pyridam Farma Tbk (ISX:PYFA) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

PT Pyridam Farma Tbk 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of PT Pyridam Farma Tbk's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Pyridam Farma Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Pyridam Farma Tbk (ISX:PYFA) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jl. Gen. Sudirman No. Kav. 21, Sinarmas MSIG Tower 12th Floor, RT.10/RW.1, Kuningan, Karet, Setiabudi District, South Jakarta City, Jakarta, IDN, 12920

Website

https://www.pyfa.co.id

PT Pyridam Farma Tbk is an Indonesia-based company, engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through the following segments: Pharmaceutical Products and Toll Manufacturing Services; and Medical Device Products. The company derives maximum revenue from Pharmaceutical Products and Toll Manufacturing Services. The company's products include consumer health, Derma, prescription, and biomedilab.

PT Pyridam Farma Tbk Headlines

No Headlines